Psyence Biomedical Ltd. Common Shares (PBM)
Psyence Biomedical Ltd. (PBM) is a life sciences company focused on researching, developing, and commercializing medical and wellness products based on psychedelic and plant-based compounds. The company aims to advance mental health treatments and promote wellness through innovative therapies and formulations, leveraging scientific expertise and emerging regulatory frameworks in the field of psychedelics.
Company News
U.S. stock futures declined ahead of the 'Triple Witching' hour, with the market expected to see the expiry of about $6.6 trillion options. Analysts have mixed views on the market's recovery by the end of the year.
Psyence Biomed, a biotechnology company focused on developing botanical psilocybin-based psychedelic medicine, announced that its $25 million equity line of credit with White Lion Capital has been declared effective by the SEC. This provides a potential funding source as the company prepares to initiate a Phase IIb clinical trial for a psilocybin-based treatment for Adjustment Disorder in Palliative Care.
Here's what types of data you should use to buy and sell penny stocks The post What Data Should You Use to Trade Penny Stocks? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.